Member Info for Techtonic

Maybe it "betrays" not " belies "my intelligence, Green.

Now, who is being obtuse and seemingly unintelligent now?

The "new" NPV data etc was widely discussed last August by all of us. It is not new data.

We went through all that test data last year. This is what was said and it doesn't seem like anything has changed. Ie Cizzle still keeping people in the dark.

This may be useful for people ...a definitive guide to tests really.

https://ebm.bmj.com/content/18/1/5

"For a test to be useful sensitivity plus specificity should be at least 1.5"

Ciz is right on this threshold for it's best results (95+ 61). Just over.

Now with PPV , it could be useful and that it will target the demographic to those more likely to have the disease.

Cizzles test certainly could be useful as guidance and better than CT scan for sure at the moment.

But, let's take the better figures (95% sensitivity, 61% specificity)..

If a cohort of 1000 people present for testing and 100 have lung cancer...

This means 95 with be correctly diagnosed, with a further 351 false positives.

So a total 443 presenting as positive, of home only 100 (minus the 8 not picked up) are truly positive.

I find still find it amazing how people think they can get into another person's thoughts and reasoning. Just go on the words not subjective feelings and bias'.

As far as the specificity is concerned, a high false positive rate will render a future LFT test almost useless (unless they've managed to tweak the process)

And since you told me I don't take an interest ( I actually said "I'm just not paying much attention anymore".. that doesn't mean I don't take an interest.

Oh and I've bought a few in recent days. So that means you can find my posts legitimate!

(I still think it's a crock, and a company that doesn't care about shareholders)

I'll be selling on a spike..enabling the purchase of a bag of chips and a Mars bar.

I wouldn't label myself a naysayer Green, although you and some on here might do!

But imo you can sum up what you've said in two lines

1) The sensitivity is great but 40% false positives is p1ss poor.

2) if they can get around this by running a dual test (without incurring prohibitive time and costs) then the test could be great.

Bubble et al didn't wait for the obvious fundraiser before piling in

Think bubble et al may find out tomorrow morning whether they are diluted into oblivion with a lower share price or get lucky with a rollover loan facility

It's ok Brond, I'm just not paying that much attention any more.

Thanks

Ps..that reply was directed at Brondby.

Vinc..there's been enough evidence over a length of time now to see what the Ciz board thinks of shareholders.

Your assumption is incorrect.

I probably have been misreading stuff because I'm not taking that much interest anymore and skin reading everything.

No malignant intent. I don't care about the share price I just don't think it's going anywhere.

Like I said a few spikes here and there.

So be good enough to correct me..or clarify.

Is Ciz getting 10% or 1.5% of overall CizBio revenues for everything excluding lung cancer test?

Ah right,

So Ciz would still receive 10% of CizBio revenues?

No, I'm not invested, but may do if I like what I see. I don't yet.

Since Ciz-bio's revenue forecast at year 3 was circa $30K, with Ciz at 10% and reciprocal reciprocal deal for CizBio at 10%.

If this is CizBio stake is now reduced to 1.5%, it puts the lung test revenue as puny.

Even if CizBio sells to China/Latin America and the Moon, and brought in sales (including other tests) of $1BILLION, Ciz would get a ridiculous $15million.

And that's with absolutely huge sales way way in the future

😆evening Troublemaker...

I have a complex case of vacillating incontinence and bladder compression regards ITM.

I've had a couple of goes at investing, which has turned into trades (at pretty much neutral outcome)

Every time I talk myself into Hydrogen gaining traction there's always something around the corner to offset it.

I think the Germany thing could be quite important, but I'm waiting it out and watching and seeing which way the wind blows.

It may be that I miss the bottom - like I did with Rolls-Royce and live to regret it, but it feels a bit risky at the moment until political clarity comes.

Dearest Troublesome,

people invested here for some time won't be wetting themselves because the share price has completely taken the p1ss !

Germany

I did post on November 8th under that very heading.

Problem is with shares people get personal and protective instead of having a fluid outlook with changing circumstances

Just your normal Cizzle Bio!

But at least you can be on holiday in Jamaica and feel easy if you lung cancer symptoms

All absolutely irrelevant until the £1.5 mill loan (inc interest) is sorted.

I've been watching trades over the last few weeks and there's been a lot of chunky sells.

Bubble, I don't know if you're doing it on purpose or it's just unconscious confirmation bias, but you've certainly talk to yourself into a position here.

Ps 3million SOLD today, not bought.

I'd be very carefully for you before the next RNS makes things clear.

Thanks Green, Trading and Cleen

Thanks everyone for that...

Any chance someone could do a copy and paste on that article.. ?

Evening/morning Cleenfreak..

Where have you seen that about the gastric cancer test?

Do you have a link?

Thanks

Evening OAPk

Think they are going to struggle to get what I believe a near £4 million fundraiser away smoothly on a loss making six million MC company - unlesd FDA come first.

Personally I think it will be very messy and probably around 2p to 3p, but that's only a guess.

Fairly obvious to me why there's been no fizz with that trading update.

· Revenue expected between £18m and £22m (unchanged)

· Adjusted EBITDA loss in the range of £32m to £36m (improved from £35m to £40m)

· Net cash at year-end in the range of £170m to £180m (improved from £160m to £175m)

All you've got there is an unchanged revenue projection, a projected loss that within the pie chart overlap could actually be higher than lower end predicted, and cash position the same logic.

Everyone reading that trading update has their own confirmation bias.

I had a few shares but sold out this morning. Pretty unimpressed by that and expected more.

You could argue that it is softly softly catchee monkey, and it may well prove to be the case, but still only inching forward.